Rhoen Klinikum AG (ETR:RHK) has been assigned a €26.50 ($31.55) price target by equities researchers at Berenberg Bank in a research note issued to investors on Wednesday. The brokerage presently has a “neutral” rating on the stock.

A number of other research firms also recently weighed in on RHK. Commerzbank Ag set a €25.00 ($29.76) target price on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Monday. DZ Bank AG reiterated a “sell” rating on shares of Rhoen Klinikum AG in a research report on Tuesday, August 29th. Independent Research GmbH set a €28.00 ($33.33) target price on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Monday, August 14th. Credit Suisse Group set a €24.40 ($29.05) target price on Rhoen Klinikum AG and gave the company a “sell” rating in a research report on Friday, August 4th. Finally, Deutsche Bank AG set a €21.00 ($25.00) target price on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Friday, August 4th. Three investment analysts have rated the stock with a sell rating and six have issued a hold rating to the company. The company has an average rating of “Hold” and an average price target of €24.06 ($28.65).

Rhoen Klinikum AG (ETR RHK) opened at 27.959 on Wednesday. The firm’s 50 day moving average price is €27.56 and its 200-day moving average price is €26.35. Rhoen Klinikum AG has a one year low of €22.91 and a one year high of €28.67. The company has a market capitalization of €1.87 billion and a PE ratio of 436.859.

TRADEMARK VIOLATION NOTICE: “Rhoen Klinikum AG (RHK) PT Set at €26.50 by Berenberg Bank” was originally published by Daily Political and is the property of of Daily Political. If you are reading this piece on another website, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this piece can be read at https://www.dailypolitical.com/2017/09/21/rhoen-klinikum-ag-rhk-pt-set-at-26-50-by-berenberg-bank.html.

Rhoen Klinikum AG Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhoen Klinikum AG (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.